The seroprevalence of entrically transmitted viral hepatitis in HCV infected thalassemia and hemophilia patients in Iran

Jundishapur Journal of Microbiology

Volumn 6, Issue 7, 2013, Pages

  Elizee, Pegah Karimi ^a,b,c   Alavian, Seyed Moayed ^a,b,c   Miri, Seyyed Mohammad ^a,b,c   Behnava, Bita ^a,b,c   Alavian, Seyedeh Hoda ^d   Keshvari, Maryam ^e   Fesharaki, Mohammad Gholami ^f   Salimi, Shima ^b,c   Mehrnoush, Leila ^b,c   Shafiei, Mostafa ^b,c  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Middle East Liver Disease Center   (Iran)

^c Tehran Hepatitis Center   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^f TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Hemophilia; Hepatitis A; Hepatitis C; Hepatitis E; Iran; Seroprevalence; Thalassemia

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FEMALE; HEMOPHILIA; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; SAMPLING; SEROPREVALENCE; THALASSEMIA; VIRUS TRANSMISSION;

HEPATITIS A VIRUS; HEPATITIS C VIRUS;

EID: 84885710956     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/ijem.9091     Document Type: Article

References (48)

1. Wasley A, Feinstone SM, Bell BP, 7th. hepatitis A virus. In: Wasley A, Feinstone SM, Bell BP, 7th, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Churchill Livingstone Elsevier; 2010. p. 2367-89.
2. Anderson DA, 7th. Hepatitis E virus. In: Anderson DA, 7th, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Churchill Livingstone Elsevier; 2010. p. 2411-23.
3. Koff RS. Risks associated with hepatitis A and hepatitis B in patients with hepatitis C. J Clin Gastroenterol. 2001;33(1):20-6.
4. Alavian SM, Miri SM, Keshvari M, Elizee PK, Behnava B, Tabatabaei SV, et al. Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia. Transfusion. 2009;49(10):2195-9.
5. Keshvari M, Alavian SM, Behnava B, Miri SM, Elizee PK, Tabatabaei SV, et al. Distribution of hepatitis C virus genotypes in iranian patients with congenital bleeding disorders. Iran Red Crescent Med J. 2010;12(6):608-14.
6. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med. 2005;8:84-90.
7. Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998;338(5):286-90.
8. Cho HC, Paik SW, Kim YJ, Choi MS, Lee JH, Koh KC, et al. Seroprevalence of anti-HAV among patients with chronic viral liver disease. World J Gastroenterol. 2011;17(2):236-41.
9. Atiq M, Shire NJ, Barrett A, Rouster SD, Sherman KE, Shata MT. Hepatitis E virus antibodies in patients with chronic liver disease. Emerg Infect Dis. 2009;15(3):479-81.
10. Farmakis D, Giakoumis A, Polymeropoulos E, Aessopos A. Pathogenetic aspects of immune deficiency associated with beta-thalassemia. Med Sci Monit. 2003;9(1):RA19-22.
11. Siagris D, Kouraklis-Symeonidis A, Konstantinidou I, Christofidou M, Starakis I, Lekkou A, et al. Prevalence of anti-HAV antibodies in multitransfused patients with beta-thalassemia. World J Gastroenterol. 2008;14(10):1559-63.
12. Alian S, Ajami A, Ghasemian R, Yadegarinia D. Age-specific seroprevalence of hepatitis A in Sari, northern Islamic Republic of Iran. East Mediterr Health J. 2011;17(10):754-8.
13. Vilibic-Cavlek T, Kucinar J, Ljubin-Sternak S, Kolaric B. Seroepidemiology of hepatitis a in the croatian population. Hepat Mon. 2011;11(12):997-9.
14. Luksamijarulkul P, Sujirarat D, Charupoonphol P. Risk Behaviors, Occupational Risk and Seroprevalence of Hepatitis B and A Infections among Public Cleansing Workers of Bangkok Metropolis. Hepat Mon. 2008;8(1):35-40.
15. Ghorbani GA. Is evaluation of hepatitis a immunity required or not? Hepat Mon. 2011;11(12):955-7.
16. Scaraggi FA, Perricci A, Petronelli M, Lomuscio S, De Mitrio V, Schiraldi O. Prevalence of serum IgG antibodies to hepatitis A virus in Italian haemophiliacs. Lancet. 1992;339(8807):1486-7.
17. Mosley JW. Has hepatitis A virus been transmitted by clotting factor concentrates among hemophiliacs in the United States? Vox Sang. 1994;67 Suppl 4:12-5.
18. Kreuz W, Klarmann D, Auerswald G, Auberger K, Gurtler L, Rabenau H, et al. Absence of hepatitis A after treatment with pasteurised factor VIII concentrates in children with haemophilia A and von Willebrand disease. Lancet. 1993;341(8842):446.
19. Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, et al. Protection against hepatitis A by an inactivated vaccine. JAMA. 1994;271(17):1328-34.
20. Mohebbi SR, Rostami Nejad M, Tahaei SM, Pourhoseingholi MA, Habibi M, Azimzadeh P, et al. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. Trans R Soc Trop Med Hyg. 2012;106(9):528-31.
21. Saffar MJ, Abedian O, Ajami A, Abedian F, Mirabi AM, Khalilian AR, et al. Age-specific seroprevalence of anti-hepatitis a antibody among 1-30 years old population of savadkuh, mazandaran, iran with literature review. Hepat Mon. 2012;12(5):326-32.
22. Ghadir MR, Jafari E, Rezvan H, Amini-Kafiabad S, Vaeze-Javadi M, Pourshams A. Hepatitis A and E in the east of Golestan province. J Med Council I.R.I. 2007;25(1):34-8.
23. Taghavi SA, Hosseini Asl MK, Talebzadeh M, Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011;11(4):285-8.
24. Shoaei P, Zeidabadinejad L, Hassannejad R, Ataei B, Yaran M, Kassaian N, et al. Seroprevalence of Hepatitis A in Patients with Chronic Hepatitis C in Isfahan Province. Int J Prev Med. 2012;3(Suppl1):S102-6.
25. Johnson Z, Thornton L, Tobin A, Lawlor E, Power J, Hillary I, et al. An outbreak of hepatitis A among Irish haemophiliacs. Int J Epidemiol. 1995;24(4):821-8.
26. Soucie JM, Robertson BH, Bell BP, McCaustland KA, Evatt BL. Hepatitis A virus infections associated with clotting factor concentrate in the United States. Transfusion. 1998;38(6):573-9.
27. Brackmann HH, Oldenburg J, Eis-Hubinger AM, Gerritzen A, Hammerstein U, Hanfland P. Hepatitis A virus infection among the hemophilia population at the Bonn Hemophilia Center. Vox Sang. 1994;67 Suppl 1:3-7.
28. Mannucci PM, Gdovin S, Gringeri A, Colombo M, Mele A, Schinaia N, et al. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group. Ann Intern Med. 1994;120(1):1-7.
29. Kedda MA, Kew MC, Cohn RJ, Field SP, Schwyzer R, Song E, et al. An outbreak of hepatitis A among South African patients with hemophilia: evidence implicating contaminated factor VIII concentrate as the source. Hepatology. 1995;22(5):1363-7.
30. Normann A, Graff J, Gerritzen A, Brackmann HH, Flehmig B. Detection of hepatitis A virus RNA in commercially available factor VIII preparation. Lancet. 1992;340(8829):1232-3.
31. Steele M, Cochrane A, Wakefield C, Stain AM, Ling S, Blanchette V, et al. Hepatitis A and B immunization for individuals with inherited bleeding disorders. Haemophilia. 2009;15(2):437-47.
32. Chambost H, Doncarli A, Bertrand MA, Briquel ME, Gay V, Pincemaille O, et al. Implementation of a hepatitis A prevention policy in haemophiliacs: results from the French cohort. Haemophilia. 2007;13(6):712-21.
33. Hayashi K, Fukuda Y, Nakano I, Katano Y, Nagano K, Yokozaki S, et al. Infection of hepatitis A virus in Japanese haemophiliacs. J Infect. 2001;42(1):57-60.
34. Toyoda H, Honda T, Hayashi K, Katano Y, Goto H, Kumada T, et al. Prevalence of hepatitis E virus IgG antibody in Japanese patients with hemophilia. Intervirology. 2008;51(1):21-5.
35. Aggarwal R, Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol. 2009;24(9):1484-93.
36. Ariyegan M, Amini S. Hepatitis E epidemic in Iran. J Med Council I.R. Irn. 1998;15:139-43.
37. Saffar MJ, Farhadi R, Ajami A, Khalilian AR, Babamahmodi F, Saffar H. Seroepidemiology of hepatitis E virus infection in 2-25-year-olds in Sari district, Islamic Republic of Iran. East Mediterr Health J. 2009;15(1):136-42.
38. Ataei B, Nokhodian Z, Javadi AA, Kassaian N, Shoaei P, Farajzadegan Z, et al. Hepatitis E virus in Isfahan Province: a populationbased study. Int J Infect Dis. 2009;13(1):67-71.
39. Taremi M, Gachkar L, MahmoudArabi S, Kheradpezhouh M, Khoshbaten M. Prevalence of antibodies to hepatitis E virus among male blood donors in Tabriz, Islamic Republic of Iran. East Mediterr Health J. 2007;13(1):98-102.
40. Assarehzadegan MA, Shakerinejad G, Amini A, Rezaee SA. Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, southwest Iran. Int J Infect Dis. 2008;12(4):387-90.
41. Shamsizadeh A., Nikfar R., Makvandi M., Shamsizadeh N. Seroprevalence of Hepatitis E Virus Infection in Children in the Southwest of Iran. Hepat Mon. 2009;9(4):261-4.
42. Taremi M, Mohammad Alizadeh AH, Ardalan A, Ansari S, Zali MR. Seroprevalence of hepatitis E in Nahavand, Islamic Republic of Iran: a population-based study. East Mediterr Health J. 2008;14(1):157-62.
43. Rostamzadeh Khameneh Z, Sepehrvand N, Masudi S. Seroprevalence of Hepatitis E among Iranian Renal Transplant Recipients. Hepat Mon. 2011;11(8):646-51.
44. al-Fawaz I, al-Rasheed S, al-Mugeiren M, al-Salloum A, al-Sohaibani M, Ramia S. Hepatitis E virus infection in patients from Saudi Arabia with sickle cell anaemia and beta-thalassemia major: possible transmission by blood transfusion. J Viral Hepat. 1996;3(4):203-5.
45. Mannucci PM, Gringeri A, Santagostino E, Romano L, Zanetti A. Low risk of transmission of hepatitis E virus by large-pool coagulation factor concentrates. Lancet. 1994;343(8897):597-8.
46. Klarmann D, Kreuz W, Kornhuber B. Low prevalence of hepatitis E virus antibodies in hepatitis C virus-positive patients with coagulation disorders. Transfusion. 1995;35(11):969-70.
47. Zaaijer HL, Mauser-Bunschoten EP, ten Veen JH, Kapprell HP, Kok M, van den Berg HM, et al. Hepatitis E virus antibodies among patients with hemophilia, blood donors, and hepatitis patients. J Med Virol. 1995;46(3):244-6.
48. Barzilai A, Schulman S, Karetnyi YV, Favorov MO, Levin E, Mendelson E, et al. Hepatitis E virus infection in hemophiliacs. J Med Virol. 1995;46(2):153-6.